Overview
- Kotak Healthcare Fund - An open ended equity scheme investing in Pharma, Healthcare and allied sectors.
- The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Portfolio
Sector | Portfolio weight |
---|---|
Pharmaceuticals and Biotechnology | 77.94 % |
Healthcare Services | 17.88 % |
Healthcare Equipment and Supplies | 2.42 % |
Net Current Assets | -0.19 % |
Type | % |
---|---|
Large Cap | 37.08 % |
Small Cap | 34.13 % |
Mid Cap | 27.03 % |
Others | 1.76 % |
Performance
Tenors | CAGR | Current Value of ₹ 10,000 invested | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Since Inception | 5Y | 3Y | 1Y | 6 M | Since Inception | 5Y | 3Y | 1Y | 6 M | |
Kotak Healthcare Fund - Direct (G) | 30.36% | - | - | 25.38% | 4.81% | 13,577.00 | - | - | 12,537.63 | 10,480.93 |
NIFTY Healthcare TRI | 30.51% | - | - | 21.88% | -0.18% | 13,584.93 | - | - | 12,187.87 | 9,981.77 |
Scheme Inception date is 11/12/2023. Mr. Abhishek Bisen, Ms. Shibani Kurian & Mr. Dhananjay Tikariha have been managing the fund since 11/12/2023. Different plans have different expense structure. The performance details provided herein are of regular plan Past performance may or may not be sustained in future. All payouts during the period have been reinvested in the units of the scheme at the thRead More
As on Feb 4, 2025
1 Year | |||||
---|---|---|---|---|---|
Average | - | - | - | - | 34.65 |
Maximum | - | - | - | - | 42.47 |
Minimum | - | - | - | - | 22.24 |
% times +ve returns | 0.00 | 0.00 | 0.00 | 0.00 | 100 |
% times returns > | 0.00 | 0.00 | 0.00 | 0.00 | 100 |
The returns are of Direct Growth Plan. Returns are calculated since inception with daily rolling frequency for the respective periods.
NAV Date | NAV | Units | Cash Flow | Scheme Value |
---|
Tenors | CAGR | Current Value of ₹ 10,000 invested | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Since Inception | 5Y | 3Y | 1Y | 6 M | Since Inception | 5Y | 3Y | 1Y | 6 M | |
Kotak Healthcare Fund - Direct (G) | 30.36% | - | - | 25.38% | 4.81% | 13,577.00 | - | - | 12,537.63 | 10,480.93 |
NIFTY Healthcare TRI | 30.51% | - | - | 21.88% | -0.18% | 13,584.93 | - | - | 12,187.87 | 9,981.77 |
Scheme Inception date is 11/12/2023. Mr. Abhishek Bisen, Ms. Shibani Kurian & Mr. Dhananjay Tikariha have been managing the fund since 11/12/2023. Different plans have different expense structure. The performance details provided herein are of regular plan Past performance may or may not be sustained in future. All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Returns >= 1 year: CAGR (Compounded Annualised Growth Rate). Note: Point to Point (PTP) Returns in INR shows the value of 10,000/- investment made at inception. Source: ICRA MFI Explorer.# Name of Scheme Benchmark. ## Name of Additional Benchmark. TRI - Total Return Index, In terms of para 6.14 of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return.
- Long term capital growth
- Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors
Details
Source: *ICRA MFI Explorer ## Risk rate assumed to be % (FBIL Overnight MIBOR rate as on NA) **Total Expense Ratio includes applicable B30 fee and GST.
Source: *ICRA MFI Explorer
## Risk rate assumed to be %
(FBIL Overnight MIBOR rate as on NA)
**Total Expense Ratio includes applicable B30 fee and GST.
- Long term capital growth
- Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors